During the past decade, St. George's Vascular Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. George's Vascular Institute" are "Abdominal Aortic Aneurysm" (2 trials), "Safety and Performance of the Nellix Endovascular Sealing System" (1 trials) and "Thoracic Diseases" (1 trials). Many other conditions were trialed in "St. George's Vascular Institute" in a lesser frequency.

Most popular intervention types in "St. George's Vascular Institute" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "CTAG Device with ACTIVE CONTROL" (1 trials), "Endovascular Aortic Aneurysm Repair (Endologix Fenestrated Stent Graft System)" (1 trials) and "Ovation™ or Ovation Prime™ Abdominal Stent Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. George's Vascular Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "St. George's Vascular Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. George's Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. George's Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".